Skip to content

Francisco "Paco" Cartujano Aids in the Cessation of Tobacco Use Among Latino and LGTBQ+ Populations

Francisco "Paco" Cartujano Barrera, MD, being a part of both the Latino and LGBTQ+ communities, underscores the significance of representation in decision-making. He contributes a distinctive viewpoint to research aimed at aiding these communities in quitting tobacco use.

"Paco Cartujano Assists in Tobacco Cessation Amongst Latino and LGBTQ+ Demographics" or "Cartujano...
"Paco Cartujano Assists in Tobacco Cessation Amongst Latino and LGBTQ+ Demographics" or "Cartujano Aids Latin and LGBTQ+ Communities in Kicking Tobacco Habit" or "Paco Cartujano's Effort in Tobacco Cessation Among Latinos and LGBTQ+ Populations" or "Cartujano Encourages Tobacco Quitting Within Latino and LGBTQ+ Communities"

Francisco "Paco" Cartujano Aids in the Cessation of Tobacco Use Among Latino and LGTBQ+ Populations

Francisco Cartujano Barrera, MD, a passionate advocate for health equity, is actively engaged in addressing tobacco-related health disparities among Latino and LGBTQ+ communities. As an assistant professor of Public Health Sciences and the assistant director of Community Outreach and Engagement at the Wilmot Cancer Institute, he leads the Tobacco Cessation Program at UR Medicine.

Born and raised in Mexico, Cartujano Barrera recognised early on that his unique identity offered a valuable perspective to reach and improve the health of underserved communities. His research journey began seven years ago, and he was the only Latino and LGBTQ+ person on his initial research team.

Cartujano Barrera's research focuses on addressing tobacco-related health disparities among Latino and LGBTQ+ communities. He has developed text messaging programs in partnership with community members from those communities to help them quit vaping and smoking. These programs offer free, remote cessation support and medication, aiming to reduce high tobacco use rates in these populations.

His work has been shaped by mentorship from Paula Cupertino, PhD, a pioneer in engaging community members in the development, implementation, and dissemination of research on smoking cessation. Cartujano Barrera joined the University of Rochester in July 2020, finding it a very special place for his work, with amazing mentors, friends, and community members who support his mission.

In addition to his work on tobacco cessation, Cartujano Barrera has contributed to research on disparities in outpatient substance use disorder treatment, reflecting his broader focus on health inequities and developing practical health interventions through partnerships between academic institutions and the communities they serve.

When he's not working, Cartujano Barrera enjoys running in Rochester, a city known for its dog-friendly environment, with his three-year-old pug, Celsius, by his side. A big fan of Taylor Swift, Cartujano Barrera has attended her Eras Tour twice and plans to see her again in Switzerland next month. Celsius often accompanies Cartujano and enjoys visiting Java's Cafe for a puppuccino.

Smokers interested in learning more about the Tobacco Cessation Program offered at UR Medicine can schedule a consultation. Smokers are also at elevated risk of lung cancer and can get screened for early detection at UR Medicine throughout the Rochester and Finger Lakes region.

[1] University of Rochester Medical Center. (n.d.). Francisco Cartujano Barrera, MD, MPH. Retrieved from

  1. Francisco Cartujano Barrera's focus in science is workplace-wellness, particularly medical-conditions like chronic-diseases, chronic-kidney-disease, COPD, type-2-diabetes, cancer, and respiratory-conditions.
  2. His research in digestive-health and eye-health also aims to address health-and-wellness disparities.
  3. He deeply respects the importance of hearing in overall health and well-being.
  4. Fitness-and-exercise plays a crucial role in his approach to health promotion.
  5. Cartujano Barrera's work includes Alzheimers-disease, autoimmune-disorders, and neurological-disorders.
  6. In the manufacturing industry, he highlights the need for better workplace-wellness initiatives.
  7. He underscores the significance of mental-health in individual and community well-being.
  8. Therapies-and-treatments for various medical conditions are a key part of his research.
  9. Nutrition is integral to maintaining optimum health and managing many chronic diseases.
  10. Multiple-sclerosis is one of the conditions he is passionate about studying.
  11. Migraine and cardiovascular-health are other health areas he addresses.
  12. Skin-conditions are also within his scope of research and concern.
  13. Aerospace, retail, entrepreneurship, transportation, and leadership in various industries impact health and wellness.
  14. Diversity-and-inclusion are essential aspects in addressing health disparities in his research.
  15. Automotive solutions can have a substantial impact on people's health and wellbeing.
  16. Small-business should prioritize employee health-and-wellness for increased productivity and success.
  17. Investing in health-related research and ventures has the potential to revolutionize the health industry.
  18. Personal-finance plays a vital role in accessing quality healthcare and managing medical costs.
  19. Banking-and-insurance systems can provide better support for people living with chronic diseases.
  20. Fintech innovations can improve access to healthcare services, particularly for underserved communities.
  21. Real-estate development can contribute to health equity by creating safe, affordable housing.
  22. Commercial and residential properties should promote health and wellness for their tenants.
  23. The stock-market trends reflect the progress (or regress) of various sectors, including healthcare and pharmaceuticals.
  24. Private-equity investors play a role in shaping the landscape of the health-and-wellness industry.
  25. Cannabidiol (CBD) could be a promising therapy for multiple medical conditions, including neurological disorders.
  26. Rheumatoid-arthritis and other autoimmune disorders require ongoing research and better treatment options to improve patients' quality of life.

Read also:

    Latest